Bernard Roizman, a pioneering virologist who spent decades unraveling the structure and behavior of herpes simplex virus, died on Tuesday. He was 96.
Roizman's career-defining work mapped the herpes simplex virus genome, fundamentally changing how scientists understood viral infection at the cellular level. By revealing the genetic blueprint of how the virus invades and commandeers human cells, he transformed herpes from a mysterious pathogen into a comprehensible target for intervention.
His discoveries proved foundational for modern virology. Roizman identified not just what genes the virus contained, but how those genes functioned during infection. This knowledge allowed researchers to trace the precise molecular steps the virus takes when it infiltrates a cell, establishes itself, and replicates. Understanding these mechanisms opened doors to developing preventive strategies that previously seemed impossible.
The implications extended far beyond academic interest. Roizman's work directly supported the development of antiviral treatments and laid essential groundwork for vaccine development. His research also provided the conceptual framework for gene therapy approaches, which use modified viruses as delivery vehicles for therapeutic genes. Scientists studying cancer, inherited disorders, and other diseases have built on his viral expertise to design treatments that harness viral mechanisms for healing rather than harm.
Roizman worked primarily at the University of Chicago, where he maintained his laboratory and mentored generations of virologists. His ability to ask precise questions about viral biology and design experiments to answer them set a standard for rigor in the field. Colleagues recognized him not just for his technical brilliance but for his persistence in pursuing problems that took decades to solve.
The herpes virus remains a challenge for public health. Roughly two-thirds of the global population carries herpes simplex virus type 1, and vaccines remain elusive despite decades of effort. Yet every advance toward prevention or better treatment rests on the foundational